| Biomarker ID | 1334 |
| PMID | 24518785 |
| Year | 2014 |
| Biomarker | miR-182 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa (4.7 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 0.976 (95% CI: 0.857-1.112) |
| Effect on Pathways | Pathways Include: synapse; presynapse; cell junction; generation of neurons; neurogenesis |
| Experiment | Prostate Cancer Vs Normal Prostate |
| Type of Biomarker | Diagnostic |
| Cohort | Cohort of 273 paraffin embedded prostate cancer samples was used. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | 0.717 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | miR-182 |